Cite
HARVARD Citation
Rizzardini, G. et al. (2019). Randomized study evaluating the efficacy and safety of switching from an an abacavir/lamivudine-based regimen to an elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide single-tablet regimen. AIDS. p. . [Online].